Emre Hamurtekin

Dr. Emre Hamurtekin


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YHYeşim HAMURTEKİN
Yeşim HAMURTEKİN
ANAmmar Nouilati
Ammar Nouilati
CDCansu Demirbatir
Cansu Demirbatir
EHEmre Hamurtekin
Emre Hamurtekin
Acetaminophen is a widely used analgesic and antipyretic agent. It is also available in over the counter formulations, which has increased its wide use. There have been many studies to date that have aimed to evaluate the mechanism of the analgesic action of acetaminophen. Additional to the inhibition of the cyclooxygenase pathway in the central nervous system, the involvement of opioidergic, cannabinoidergic, dopaminergic, cholinergic, and nitrergic systems as well as the contribution of descending pain inhibitory systems like the bulbospinal serotonergic pathway has been proposed as possible mechanisms of the analgesic action of acetaminophen. In this review, we aimed to collect the data from studies revealing the contribution of the central serotonergic system and the role of central nervous system-located serotonergic receptor subtypes in the analgesic effect of acetaminophen. While doing this, we mainly focused on the research that has been performed in the last ten years and tried to link the previous data with the lately added results. In addition to serotonergic system involvement, we also reviewed the role of nitric oxide in the analgesic action of acetaminophen, especially with the new findings reported over the last decade.

27 February 2023 in Nigerian Journal of Clinical Practice
Verified
Journal Article
Open access
EHEmre Hamurtekin
Emre Hamurtekin
ABAS Boşnak
AS Boşnak
AAA Azarbad
A Azarbad
RMR Moghaddamshahabi
R Moghaddamshahabi
YHY Hamurtekin
Y Hamurtekin
RNRb Naser
Rb Naser
Background: There are concerns about inappropriate use and insufficient knowledge of proton pump inhibitors (PPIs) use among medical staff. Aims: This study was designed to examine pharmacy students’ and community pharmacists’ knowledge, attitude, and practices toward PPIs and their relationship with specific sociodemographic characteristics. Subjects and Methods: This descriptive study was conducted on the pharmacy students (first and last year) at Eastern Mediterranean University and community pharmacists in North Cyprus Data were collected by a validated questionnaire, which assessed knowledge, attitude, and practices regarding PPI use. Students were included without sampling in a volunteer-based manner. Registered community pharmacists were selected randomly. Results: First-year pharmacy students (n = 77) showed significantly lower knowledge levels than last-year students (12.00 vs. 13.65; P < 0.001); however, there was no significant difference between last-year students (n = 111) and community pharmacists (n = 59). First-year pharmacy students were significantly less aware of PPIs’ “dosage and administration” than the other two groups. Last-year students and community pharmacists exhibited significantly higher attitude scores regarding PPI use (24.7 and 24.6 vs. 22.7; P < 0.001). Omeprazole was found to be the most preferred PPI among the three studied populations. Community pharmacists used PPIs mainly to treat acid reflux. Gender, nationality, and pharmacy education program type did not influence pharmacy students’ knowledge, attitude, or practices. Conclusions: There was not a significant difference regarding knowledge and attitude between the last-year pharmacy students and community pharmacists. The practices of community pharmacists were significantly different from the pharmacy students. It was concluded that certain essential topics regarding PPI use should be emphasized in pharmacy education and during pharmacy practice. Further, it is essentially important for community pharmacists to continue their education through training programs after graduation to enhance their knowledge of PPI use.

31 December 2019 in Clinical and Experimental Health Sciences
Verified
Journal Article
Open access
PDF file
EBElif Baris
Elif Baris
MAMualla Aylin Arici
Mualla Aylin Arici
EHEmre Hamurtekin
Emre Hamurtekin
Sepsis is a severe and multifaceted condition of body in response to an infection, which affects multiple organs systems that makes it difficult to treat and enhances the mortality rates. Release of inflammatory cytokines can initiate an inflammatory response during sepsis. However, the response can be modified by the control mechanism inside the body that are essential for the keeping the balance and survival. The cholinergic anti-inflammatory pathway is defined as a comprehensive neurohumoral pathway that diminishes pro-inflammatory cytokine release through the vagus nerve and cholinergic receptors, predominantly α7 nicotinic acetylcholine receptors (α7nAChR) that expressed on inflammatory mononuclear cells. Thus, cholinergic agonists might be a part of prospective treatment approach in inflammatory diseases such as sepsis. This review covers the role of cholinergic system in prostaglandin mediated inflammatory response.

1 January 2023 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
EHEmre Hamurtekin
Emre Hamurtekin

3 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SRShideh Roshani
Shideh Roshani
FSFatima Serhan
Fatima Serhan
ANAntonella Naddaf
Antonella Naddaf
IKImge Kunter
Imge Kunter
HKHala Khalife
Hala Khalife
HGHala Gali-Muhtasib
Hala Gali-Muhtasib
More than three decades have passed since adult T-cell leukemia/lymphoma (ATL) was first identified as a distinct disease in Japan. During this time, researchers discovered its causative agent—the human T-cell leukemia virus type 1 (HTLV-1). HTLV-1 infection has a significant global prevalence, affecting an estimated 5–10 million individuals worldwide. In this review, we provide a comprehensive overview of HTLV-1 persistence, latency, replication, and oncogenesis, with a particular focus on the roles of viral proteins such as Tax, HBZ, Rex, p30, p12, and p8. Understanding these mechanisms is essential for developing effective therapeutic strategies against HTLV-1-associated diseases, including ATL. Additionally, we explore current treatment strategies for ATL, including conventional chemotherapy, allogeneic hematopoietic cell transplantation, and epigenetic therapies. Gaining deeper insights into HTLV-1 pathogenesis, its molecular drivers and the existing therapeutic approaches can pave the way for more refined and innovative strategies to combat HTLV-1-associated malignancies.

1 February 2025 in International Journal of Pharmacology
Verified
Journal Article
Closed access
Shideh RoshaniShideh Roshani
Shideh Roshani
EBElif Baris
Elif Baris
ABAhmet Sami Bosnak
Ahmet Sami Bosnak
HGHala Gali-Muhta
Hala Gali-Muhta
EHEmre Hamurtekin
Emre Hamurtekin
Effect of Choline and CDP-Choline on Inflammation and Oxidative Stress in Burkitt’s Lymphoma Cells